Skip to main content

MoneyWorks4Me

The sales for the September 2026 quarter moved up 38.95% to Rs. 57.90 millions as compared to Rs. 41.67 millions during the corresponding quarter last year.The Net Loss for the quarter ended September 2026 is Rs. -53.99 millions as compared to Net Loss of Rs. -61.43 millions of corresponding quarter ended September 2025 Operating profit Margin for the quarter ended September 2026 improved to -18.92% as compared to -27.86% of corresponding quarter ended September 2025


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 57.90 41.67 38.95 127.74 96.48 32.40 237.32 433.12 -45.21
Other Income 0.37 0.07 428.57 1.94 0.19 921.05 20.26 7.09 185.75
PBIDT -18.92 -27.86 -32.09 -9.09 -48.61 -81.30 -34.23 -143.21 -76.10
Interest 19.02 17.33 9.75 37.83 33.83 11.82 70.86 59.14 19.82
PBDT -37.94 -45.19 -16.04 -46.92 -82.44 -43.09 -105.09 -202.35 -48.07
Depreciation 16.05 16.24 -1.17 31.93 32.23 -0.93 64.23 66.89 -3.98
PBT -53.99 -61.43 -12.11 -78.85 -114.67 -31.24 -169.32 -269.24 -37.11
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.15 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -53.99 -61.43 -12.11 -78.85 -114.67 -31.24 -169.32 -269.39 -37.15
Equity 215.61 215.61 0.00 215.61 215.61 0.00 215.61 215.61 0.00
PBIDTM(%) -32.68 -66.86 -51.13 -7.12 -50.38 -85.88 -14.42 -33.06 -56.38
Peers
Company Name CMP
Sun Pharma. Inds. 1771.95
Dr. Reddys Labs. 1370.00
Cipla 1392.20
Lupin 2012.00
Zydus Lifesciences 1239.00
View more..